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Abstract
In the present article we review the main published data on the application of Tissue Doppler
Imaging (TDI) to stress echocardiography for the detection of myocardial ischemia. TDI has been
applied to stress echocardiography in order to overcome the limitations of visual analysis for
myocardial ischemia. The introduction of a new technology for clinical routine use should pass
through the different phases of scientific assessment from feasibility studies to large multicenter
studies, from efficacy to effectiveness studies. Nonetheless the pro-technology bias plays a major
role in medicine and expensive and sophisticated techniques are accepted before their real
usefulness and incremental value to the available ones is assessed. Apparently, TDI is not exempted
by this approach : its applications are not substantiated by strong and sound results. Nonetheless,
conventional stress echocardiography for myocardial ischemia detection is heavily criticized on the
basis of its subjectivity. Stress echocardiography has a long lasting history and the evidence
collected over 20 years positioned it as an established tool for the detection and prognostication
of coronary artery disease. The quantitative assessment of myocardial ischemia remains a scientific
challenge and a clinical goal but time has not come for these newer ultrasonographic techniques
which should be restricted to research laboratories.
Pharmacologic stress echocardiography is an established
cost-effective technique for the detection of coronary
artery disease [1]. The widespread use in the clinical prac-
tice has become possible only after evidence collected
through large scale multicenter studies that demonstrated
its feasibility, safety, diagnostic and prognostic accuracy
[4-8]. According to the guidelines of ACC/AHA – pharma-
cological stress echocardiography with either dobutamine
or dipyridamole is a class I indication (of documented
effectiveness and usefulness) for the diagnosis of coronary
artery disease and for the prognostic stratification of
patients with known coronary artery disease [2,3]. Its
major limitation is related to a high inter-observer varia-
bility and to operator-dependent expertise that might be
overcome by an appropriate training and the use of strict
reading criteria [9-11]. Nonetheless the hunt for an objec-
tive, operator-independent technique to be applied to the
conventional black and white regional wall motion anal-
ysis remains a major goal in stress echocardiography. Tis-
sue Doppler Imaging (TDI) provides a quantitative
analysis of regional myocardial function through the anal-
ysis of myocardial velocities [12,13]. Since velocity imag-
ing is confounded by influence from velocities in other
segments, the TDI – based modalities strain and strain rate
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ening fraction and shortening rate, respectively [14] Is the
application of Tissue Doppler Imaging to stress echocardi-
ography the technique that will solve it all? According to
major journals the answer is yes: the diagnostic accuracy
of stress echocardiography improves with TDI when ana-
lyzed in comparison with visual assessment of wall
motion analysis for the detection of inducible ischemia.
Inducible ischemia quantified in a number without the
approximations of visual assessment. However the enthu-
siasm showed by some investigators is not substantiated
by scientific results. In fact, a careful analysis of the data
published so far raises more doubts than certainties.
What we talk about when we talk about TDI
The TDI modalities include myocardial velocity imaging,
displacement imaging, strain rate imaging and strain
imaging. TDI measures velocities by the Doppler shift of
reflected ultrasound. Velocities are measured in the con-
ventional imaging planes, from apical views as longitudi-
nal velocities and from parasternal views as radial
velocities. When we employ TDI, the velocities within a
myocardial segment are the net result of motion caused by
contractions in that segment, motion due to tethering to
other segments, and overall motion of the heart. This teth-
ering effect is the reason why longitudinal velocities
increase progressively from the apex toward the base,
when measured in an apical window. Therefore ischemia
in the apical region reduces myocardial velocities not only
in the apex, but also in the nonischemic basal segments
[15]. In practical terms, the reduction of TDI velocities in
basal segments is not synonymous of reduction of func-
tion in the same segments. The opposite effect, tethering
of nonischemic segments might induce increase in veloc-
ity of adjacent ischemic segments. These limitations could
be overcome by the employment of strain and strain rate.
Strain rate reflects how fast regional myocardial shorten-
ing or lengthening occurs measured at two locations sep-
arated by a distance. This is the reason why some authors
define strain rate as a spatial velocity gradient. Strain is
calculated as the time integral of strain rate and is a
dimensionless quantity. The limitations of TDI have been
widely outlined [16-18] and this is beyond the scope of
the present review but they may be synthesized into two
main problems: 1 – the amplitude of the estimated veloc-
ity is dependent on the angle at which the region is
imaged; 2 – the overall cardiac motion, rotation, and con-
traction of adjacent segments will influence regional
velocity estimates. Therefore, a more critical approach to
this technology would have avoided the inconsistencies of
scientific results when it was applied in the clinical arena.
TDI and Stress echocardiography for myocardial 
ischemia detection
Feasibility studies have been published demonstrating the
applicability of TDI to stress echocardiography [19-27]
but only few studies addressed the issue of its diagnostic
accuracy in a clinical context [28-31].
Cain et al [28] applied myocardial Doppler velocity to
dobutamine stress echocardiography in order to assess its
diagnostic accuracy when compared to conventional vis-
ual assessment. They first identified the normality ranges
of myocardial velocities in patients with normal coronary
arteries or with a very low pretest probability of having
coronary artery disease. Then they selected 114 patient
with coronary artery disease assessed at coronary angiog-
raphy and evaluated the diagnostic accuracy: see Table 1
(Additional file 1). Neither overall nor vascular territory
accuracy was better for myocardial velocity when com-
pared to visual wall motion scoring. The MYDISE Study
[29] was the first multicenter study on the absolute value
of TDI applied to dobutamine stress echocardiography.
The study enrolled 289 patients separated in 3 groups:
group 1 (n = 92) healthy volunteers or patients with nor-
mal coronary arteries, group 2 (n = 48) patients with
known coronary artery disease and group 3 (n = 149) con-
secutive patients with known or suspected coronary artery
disease. Exclusion criteria were: atrial fibrillation, previ-
ous myocardial infarction (Q waves on the electrocardio-
gram, or akinetic segments on the resting
echocardiographic images), previous revascularization,
unstable angina, complete bundle branch block, signifi-
cant heart valve disease, contraindication to dobutamine
or atropine). The diagnostic criteria were developed by
comparing 92 normal subjects with 48 patients with cor-
onary artery disease and applied in a prospective series of
149 patients referred to stress echo laboratory for the sus-
pect of coronary artery disease. Velocity cut-off points
were tested and discarded since they did nor perform well
when compared to logistic regression models, using systo-
lic velocities at peak stress in 7 myocardial segments and
after adjusting for heart rate, age and gender [29].
The main concerns refer to strict stress echocardiographic
issues:1.the lack of a comparison between conventional
visual assessment of regional wall motion and TDI analy-
sis. In absolute terms the diagnostic accuracy is not strik-
ing: see Table 1 (Additional file 1) and Fig 1. Even if we
accept the hypothesis of a non-inferiority analysis of TDI
versus dobutamine stress echocardiography we have to
take into consideration some major limitations outlined
by the authors: the optimal diagnostic accuracy was
obtained by using peak systolic velocity after adjusting for
maximal heart rate, age and gender: "ignoring these fac-
tors reduces both sensitivity and specificity" [29]. Moreo-
ver, authors applied a very complex regression model forPage 2 of 6
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dobutamine stress echocardiography showed an overall
sensitivity of 80% and a specificity of 87% [32] (see fig 2).
2 – The extent and severity of myocardial ischemia as
defined by the number of ischemic segments and the
pharmacologic load is never provided. The protocol was
interrupted only in the presence of secondary criteria, but
never for development of myocardial ischemia since the
quantitative analysis was performed off-line. It has been
demonstrated that diagnostic and prognostic accuracy of
stress echocardiography increases when the response is
stratified in the time and space domain, i.e. number of
ischemic segments, severity of ischemia induced, the time
of onset of ischemia and the pharmacologic dose. 3 – the
apical segments have been excluded by the analysis since
the systolic velocity is not reliable making the analysis
possible only in 11 segments. Nonetheless, the apex and
the apical segments are very often the site of stress
echocardiographic positivity unless very proximal athero-
sclerotic lesions are present 4 – the time for performing
analysis is never reported. We are informed that the com-
parison between systolic velocities at rest and at peak
stress is disregarded since it is time consuming and
increases the potential for observer variability without
increasing diagnostic accuracy. 5 -, apparently, TDI cannot
be applied to patients with wall motion abnormalities at
rest. The exclusion of this group of patients makes this
quantitative approach quite unfeasible for routine clinical
application.
Voigt et al. [30] used a more realistic approach to the
application of TDI to stress echocardiography. They first
Sensitivity and specificity of dobutamine stress echocardiographyFigure 2
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onary artery disease that strain rate quantitatively
differentiates ischemic and nonischemic regional myocar-
dial response to dobutamine stress echocardiography [30]
and compared it with conventional visual assessment. The
ratio of postsystolic shortening to maximal strain was the
best quantitative parameter to identify dobutamine stress
induced-ischemia. This quantitative analysis improved
sensitivity from 81 (visual assessment) to 86% and specif-
icity from 82% to 89%. The statistical significance is not
provided in the manuscript. Then, in the same population
of 44 [31], they compared the visual assessment of wall
motion abnormalities with different parameters derived
from TDI application such as peak systolic velocity, systo-
lic displacement and strain rate imaging. They employed
simultaneous perfusion scintigraphy as a gold standard of
myocardial ischemia. The stress echocardiographic meth-
odology employed was not a standard one for segmenta-
tion of the left ventricle (18 segments instead of 16 or 17),
pharmacologic protocol (up to 2 mg atropine instead of 1
mg) and criteria for ischemia (worsening of wall motion
only in 1 segment). Also in this case, the overall accuracy
is not striking: Table 1 (Additional file 1). On the basis of
these results TDI reduces significantly the diagnostic accu-
racy of dobutamine stress echocardiography whereas
strain rate imaging equals the diagnostic accuracy but it
does not improve it. Interestingly enough, the sensitivities
and specificities of strain rate imaging are slightly different
in the two papers even though the analysis was conducted
in the very same set of patients. Moreover, since coronary
angiography was performed in all patients, the diagnostic
accuracy should have been calculated on this real gold
standard instead of perfusion scintigraphy.
In a recent [33] article Marwick et al. questioned the
hypothesis that false-negative results of dobutamine stress
echocardiography reflect the underinterpretation of
regional left ventricular function. On the opposite, the
quantitative parameters such as strain rate and peak systo-
lic strain rate were no different between false and true neg-
ative tests, suggesting that false-negative results are related
to lack of ischemia in a functional sense. On the basis of
this observation, quantitative markers are unlikely to
increase the sensitivity of dobutamine stress
echocardiography.
In the left panel sensitivities and specificities in the three main vascular districts and overall sensitivities and specificities without corr cting results for age, ge er and heart ra eFigure 1
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The quantitative interpretation of stress echocardiography
is not superior to expert wall motion assessment. Open
issues in the quantitative analysis remain at stake: which
technique to be employed among systolic velocities,
strain and strain rate, the assessment of normality criteria
of myocardial velocities and how to interpret their values,
the management of patients with regional and global left
ventricular dysfunction, the analysis of the apical seg-
ments, the complexity of the analysis in a real clinical
environment, the applicability to unselected populations,
its unsuitability to exercise, the most widely used stressor
in the clinical practice [34]. What is presented as a break-
through technology should have already answered to
these issues and when exported into the clinical arena
should have provided an incremental value to the estab-
lished and more easily accessible methods. It is at this
point that we are lost in clinical translation: authoritative
journals provide data that cannot be transferred into the
daily life of a busy stress echocardiographic laboratory,
although the general message is optimistic and tend to
ignore flaws and limitations of the technique [35,36]).
The advantage/disadvantage balance of a new technology
should clearly be stated. The potential advantages should
always outweigh the disadvantages related to the higher
costs and higher complexity of analysis. Perhaps, the
shape of the quantitative technology to come has not
been designed yet [37,38]. TDI is one of the tools in our
hands but apparently this is not its time. At least not on
the basis of this evidence.
Additional material
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